483
Kathleen M. Mullane, D.O.Kathleen M. Mullane, D.O. – FDA 483, Oct 20, 2020
Record Details
Kathleen M. Mullane, Clinical Investigator, was inspected by the FDA, revealing significant deviations from investigational plans and inadequate record-keeping. The inspection found instances where study drugs were administered contrary to protocol, prohibited medications were given, and eligibility assessments were not properly documented. Additionally, serious adverse events were not reported to the sponsor within the required timeframe, and case histories lacked essential data.
View Company Profile
ID · c6311e01-4867-4ec5-852f-fc353f2dff8a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.